PTK2B (Protein Tyrosine Kinase 2 Beta), also known as PYK2, is a non-receptor tyrosine kinase regulating cytoskeletal reorganization, cell migration, immune responses, and bone remodeling . Phosphorylation at Tyr579 facilitates interactions with SRC family kinases, activating downstream pathways like MAPK and Rho GTPases . Dysregulation of PTK2B is linked to inflammatory diseases, including ulcerative colitis (UC), where elevated PTK2B levels correlate with neutrophil activation and mucosal inflammation .
UC Pathogenesis: PTK2B (Ab-579) detects elevated PTK2B levels in inflamed colonic mucosa of UC patients, correlating with disease severity .
Neutrophil Migration: Validates PTK2B’s role in neutrophil migration via CXCR2/GRK2-p38 MAPK signaling .
Western Blot: Confirms PTK2B expression in 3T3 cells (mouse fibroblasts) .
Phosphorylation Analysis: Distinguishes activated PTK2B in signaling cascades, such as SRC-mediated pathways .
Specificity Testing: Pre-adsorption with phosphorylated immunogen abolishes signal, confirming epitope specificity .
Cross-Reactivity: Validated in human, mouse, and rat tissues .
PTK2B (Ab-579) Antibody enables critical investigations into:
PTK2B (also known as PYK2, FAK2, or RAFTK) is a non-receptor protein-tyrosine kinase that plays crucial roles in multiple cellular processes. It regulates reorganization of the actin cytoskeleton, cell polarization, cell migration, adhesion, spreading, and bone remodeling . In immune cells, PTK2B is required for normal levels of marginal B-cells in the spleen, normal migration of splenic B-cells, and proper macrophage polarization and migration towards sites of inflammation . PTK2B functions downstream of numerous receptor types, including integrin and collagen receptors, immune receptors, G-protein coupled receptors (GPCRs), and cytokine/chemokine/growth factor receptors . It also mediates responses to cellular stress through formation of multisubunit signaling complexes with SRC and SRC family members, leading to phosphorylation events that create binding sites for scaffold proteins, effectors, and substrates .
Tyrosine 579 (Tyr579) represents an important phosphorylation site in PTK2B that occurs downstream of initial Tyr402 phosphorylation. The phosphorylation sequence typically follows this pattern: phosphorylation at Tyr-402 promotes interaction with SRC and SRC family members, leading to subsequent phosphorylation at Tyr-579, Tyr-580, and Tyr-881 . Specifically, phosphorylation at Tyr579 occurs after PTK2B interacts with SRC family kinases and is critical for full kinase activation and downstream signaling events . This phosphorylation site is part of a regulatory mechanism that controls PTK2B's ability to activate numerous signaling pathways, including the MAP kinase cascade, Rho family GTPases, and AKT signaling .
PTK2B (Ab-579) Antibody is typically generated using a synthesized non-phosphopeptide derived from human PYK2 around the phosphorylation site of tyrosine 579 with the amino acid sequence E-D-Y(p)-Y-K . The antibody is produced in rabbits and is polyclonal in nature . After collection, the antibody is affinity-purified from rabbit antiserum using affinity-chromatography with the epitope-specific immunogen .
The specificity of the antibody depends on the exact product. Some versions detect endogenous levels of total PYK2 protein regardless of phosphorylation state , while phospho-specific versions detect PYK2 protein only when phosphorylated at Y579 . The antibody shows cross-reactivity with human and mouse PTK2B .
Based on the provided information, PTK2B (Ab-579) Antibody demonstrates reactivity with:
This cross-species reactivity makes the antibody useful for comparative studies across different model systems. Western blot analyses specifically show detection of PTK2B in human cell lines and mouse 3T3 cells .
For optimal Western blot results with PTK2B (Ab-579) Antibody, follow these methodological recommendations:
Sample preparation: Prepare cell or tissue lysates in a buffer containing phosphatase inhibitors to preserve phosphorylation status. PTK2B is approximately 116-125 kDa.
Antibody dilution: Start with a 1:1000 dilution and adjust based on signal strength. The recommended dilution range is 1:500-1:3000 .
Blocking conditions: Use 5% non-fat dry milk or BSA in TBST for 1 hour at room temperature. For phospho-specific detection, BSA is preferred over milk as blocking agent.
Incubation time and temperature: Primary antibody incubation should be performed overnight at 4°C for optimal results.
Controls: Include a positive control (e.g., 3T3 cells) that is known to express PTK2B . Consider using a peptide competition assay as demonstrated in Western blot analyses where the lane treated with synthesized peptide shows eliminated or reduced signal .
Detection system: Both chemiluminescence and fluorescence-based detection systems are suitable, with the choice depending on the desired sensitivity and equipment availability.
Based on the available data, the following cellular models have been successfully used to study PTK2B phosphorylation at Tyr579:
3T3 cells: Mouse fibroblast cells show detectable levels of PTK2B and have been used in Western blot validation of the antibody .
Jurkat cells: Human T lymphocyte cells demonstrate expression of PTK2B and are useful for studying PTK2B in immune signaling contexts .
RAW264.7 cells: Murine macrophage cell line expresses PTK2B and is valuable for studying PTK2B in the context of innate immune responses .
A431 cells: Human epidermoid carcinoma cells express PTK2B and have been used for immunocytochemistry applications .
When selecting a cellular model, consider the following factors:
The signaling pathway of interest (immune, adhesion, migration)
Species compatibility with the antibody
Endogenous expression levels of PTK2B
Presence of stimuli that can induce PTK2B phosphorylation
To properly validate the specificity of PTK2B (Ab-579) Antibody for your experiments, follow these methodological approaches:
Peptide competition assay: Pre-incubate the antibody with the immunizing peptide before application to your sample. The specific signal should be significantly reduced or eliminated, as demonstrated in Western blot analyses where the lane treated with synthesized peptide shows eliminated signal .
Phosphatase treatment: For phospho-specific antibodies, treat half of your sample with lambda phosphatase to remove phosphate groups. The signal should disappear in the treated sample if the antibody is truly phospho-specific.
Genetic approaches: Use PTK2B knockdown or knockout cell lines/tissues as negative controls. The specific band or staining should be absent in these samples.
Multiple detection methods: Confirm your findings using alternative methods (e.g., mass spectrometry) or different antibodies targeting other regions of PTK2B.
Cross-reactivity assessment: Test the antibody on samples known to express closely related proteins (like PTK2/FAK1) to ensure it does not cross-react with these proteins.
For rigorous phosphorylation studies using PTK2B (Ab-579) Antibody, include these essential controls:
Positive control: Cell lysate or tissue known to express phosphorylated PTK2B at Tyr579, such as 3T3 cells .
Negative control:
Unstimulated cells (basal conditions where phosphorylation is minimal)
Samples treated with tyrosine kinase inhibitors that block PTK2B activation
Phosphatase-treated samples
Peptide competition control: Antibody pre-incubated with the immunizing peptide to demonstrate specificity .
Antibody controls:
Primary antibody omission control
Isotype control (rabbit IgG)
Total PTK2B antibody to assess total protein levels alongside phosphorylation status
Loading control: Antibody against housekeeping protein (β-actin, GAPDH) to ensure equal loading across samples.
Stimulation experiments: Controlled treatments that induce PTK2B phosphorylation, such as:
While the provided search results don't specifically detail an immunoprecipitation (IP) protocol for PTK2B (Ab-579) Antibody, some variants of anti-PTK2B antibodies are validated for IP . Based on general IP principles and the properties of this antibody, here is a recommended protocol:
Cell lysis:
Harvest cells and lyse in non-denaturing lysis buffer (e.g., 50 mM Tris-HCl pH 7.4, 150 mM NaCl, 1% NP-40, 0.5% sodium deoxycholate)
Include protease inhibitors (e.g., PMSF, aprotinin, leupeptin)
For phosphorylation studies, add phosphatase inhibitors (e.g., sodium orthovanadate, sodium fluoride, β-glycerophosphate)
Clear lysate by centrifugation (14,000 × g for 15 minutes at 4°C)
Pre-clearing (optional but recommended):
Incubate lysate with Protein A/G beads for 1 hour at 4°C
Remove beads by centrifugation
Immunoprecipitation:
Add 2-5 μg of PTK2B (Ab-579) Antibody to 500 μg-1 mg of pre-cleared lysate
Incubate overnight at 4°C with gentle rotation
Add 30-50 μL of Protein A beads (as the primary antibody is rabbit-derived)
Incubate for 2-4 hours at 4°C with gentle rotation
Washing:
Collect beads by centrifugation at 2,000 × g for 2-3 minutes
Wash 3-5 times with lysis buffer
Elution and Analysis:
Elute proteins by boiling beads in SDS sample buffer
Analyze by SDS-PAGE and Western blotting
Controls:
Input control (5-10% of lysate used for IP)
Negative control using rabbit IgG instead of specific antibody
When interpreting Western blot results using PTK2B (Ab-579) Antibody, consider these key points:
Expected band size: PTK2B has a molecular weight of approximately 116-125 kDa. Verify that your detected band appears at this size.
Phosphorylation status interpretation:
If using a phospho-specific antibody, the signal intensity reflects the relative level of Tyr579 phosphorylation
Compare with total PTK2B levels using a non-phospho-specific antibody in parallel samples
Calculate the phospho-PTK2B/total PTK2B ratio to quantify relative phosphorylation levels
Multiple bands interpretation:
Stimulation experiments:
Quantitative analysis:
Use densitometry to quantify band intensity
Normalize to loading controls
Present data as fold-change relative to control conditions
Several factors can lead to false positive or false negative results when using PTK2B (Ab-579) Antibody:
Potential causes of false positives:
Cross-reactivity: The antibody might recognize structurally similar proteins, especially other FAK family members.
Non-specific binding: Insufficient blocking or high antibody concentration can lead to non-specific signals.
Sample contamination: Contamination during sample preparation can introduce proteins that generate non-specific signals.
Detection system issues: Excessive exposure time or highly sensitive detection reagents can amplify background signals.
Secondary antibody cross-reactivity: The secondary antibody might recognize endogenous immunoglobulins in your sample.
Potential causes of false negatives:
Protein degradation: Improper sample handling or insufficient protease inhibitors can lead to PTK2B degradation.
Phosphatase activity: Inadequate phosphatase inhibition during sample preparation can result in dephosphorylation of Tyr579.
Epitope masking: Protein-protein interactions or other post-translational modifications might block antibody access to the epitope.
Insufficient protein loading: Too little protein loaded can result in signal below detection threshold.
Inefficient transfer: Problems during protein transfer from gel to membrane can reduce signal intensity.
Antibody storage issues: Improper storage conditions (repeated freeze-thaw cycles, inappropriate temperature) can reduce antibody activity .
Phosphorylation at Tyr579 in PTK2B plays a critical role in protein-protein interactions and downstream signaling:
Sequential phosphorylation events: Tyr579 phosphorylation typically occurs after initial autophosphorylation at Tyr402. The process generally follows this sequence: phosphorylation at Tyr-402 promotes interaction with SRC and SRC family members, leading to subsequent phosphorylation at Tyr-579, Tyr-580, and Tyr-881 .
SRC family kinase interactions: Phosphorylation at Tyr579 (along with Tyr580) creates binding sites for SH2 domain-containing proteins, particularly SRC family kinases, stabilizing their interaction with PTK2B and facilitating full kinase activation .
Scaffold function: Phosphorylated PTK2B acts as a scaffold for the assembly of multiprotein signaling complexes. For example, it can bind to both PDPK1 and SRC, thereby allowing SRC to phosphorylate PDPK1 at multiple tyrosine residues .
Downstream effector activation: Tyr579 phosphorylation contributes to PTK2B's ability to activate multiple signaling pathways, including:
Cytoskeletal regulation: Phosphorylated PTK2B regulates focal adhesion dynamics, cell migration, and cytoskeletal reorganization through interactions with proteins like paxillin (PXN) and ASAP1/2 .
To distinguish specific PTK2B phosphorylation signal from background in immunofluorescence experiments:
Proper controls:
Include a negative control with primary antibody omitted
Use isotype control antibody (rabbit IgG) at the same concentration
Perform peptide competition by pre-incubating the antibody with immunizing peptide
Include positive controls (cells known to express phosphorylated PTK2B)
Optimization strategies:
Signal validation techniques:
Compare staining pattern with known PTK2B localization (cytoplasm, perinuclear region, cell membrane, focal adhesions, lamellipodia)
Co-stain with antibodies against proteins known to colocalize with PTK2B (SRC, integrins)
Treat cells with stimuli known to induce PTK2B phosphorylation and observe increased signal
Compare with cells where PTK2B expression is knocked down
Image acquisition and analysis:
Use identical exposure settings for all samples
Collect z-stacks to capture the full signal distribution
Implement quantitative image analysis to measure signal intensity relative to background
Consider advanced techniques like FRET if assessing protein-protein interactions
The relationship between Tyr402 and Tyr579 phosphorylation represents a sequential activation mechanism in PTK2B signaling:
Initiation by Tyr402 phosphorylation:
Tyr402 is the major autophosphorylation site of PTK2B
This phosphorylation occurs in response to various stimuli that elevate intracellular calcium concentration
The activation is often indirect and may be mediated by production of reactive oxygen species (ROS)
Autophosphorylation occurs in trans, where one subunit of the dimeric receptor phosphorylates tyrosine residues on the other subunit
Recruitment of SRC family kinases:
Secondary phosphorylation events:
Functional significance:
Tyr402 phosphorylation serves as the initiating event in PTK2B activation
Tyr579 phosphorylation (along with Tyr580) enhances kinase activity and creates additional protein binding sites
Tyr881 phosphorylation is important for interaction with GRB2 and activation of downstream pathways like the MAP kinase cascade
Regulatory mechanisms:
PTK2B (Ab-579) Antibody provides a valuable tool for investigating the intersection of calcium signaling and tyrosine kinase pathways:
Calcium-dependent activation studies:
Use the antibody to detect PTK2B phosphorylation at Tyr579 following treatments with calcium ionophores, thapsigargin (which depletes ER calcium stores), or physiological stimuli that increase intracellular calcium
Compare the timing and magnitude of phosphorylation with calcium flux measurements using fluorescent indicators
Determine whether calcium-dependent kinases (like CAMKs) act upstream of PTK2B phosphorylation
G-protein coupled receptor (GPCR) signaling:
Investigate how GPCRs that activate phospholipase C and trigger calcium release affect PTK2B phosphorylation
Study the role of PTK2B in integrating GPCR and integrin signaling by examining Tyr579 phosphorylation in cells with manipulated integrin expression or activation
Mechanistic studies:
Use calcium chelators (BAPTA-AM) to determine calcium-dependency of PTK2B phosphorylation
Employ reactive oxygen species (ROS) scavengers to assess the contribution of ROS to calcium-induced PTK2B activation
Investigate how calcium signaling influences the formation of complexes between PTK2B and SRC family kinases
Downstream pathway integration:
Examine how PTK2B phosphorylation at Tyr579 influences calcium-dependent and independent signaling pathways
Study the role of PTK2B in calcium-regulated processes like NMDA receptor function and ion channel regulation
Investigate PTK2B's contribution to calcium-dependent cellular processes such as migration, adhesion, and cytoskeletal reorganization
Temporal dynamics analysis:
Use time-course experiments with PTK2B (Ab-579) Antibody to determine the relationship between calcium flux and PTK2B phosphorylation
Implement phospho-specific flow cytometry for single-cell resolution of calcium-induced PTK2B activation
To investigate the temporal dynamics of PTK2B phosphorylation at Tyr579, consider these methodological approaches:
Time-course Western blot analysis:
Stimulate cells with activators of PTK2B (calcium ionophores, angiotensin II, thapsigargin, LPA)
Collect samples at multiple time points (e.g., 0, 1, 5, 15, 30, 60, 120 minutes)
Analyze PTK2B phosphorylation at Tyr579 using PTK2B (Ab-579) Antibody
Quantify phosphorylation levels by densitometry and normalize to total PTK2B
Real-time imaging techniques:
Generate cells expressing fluorescent protein-tagged PTK2B
Use FRET-based biosensors that report on PTK2B phosphorylation status
Perform live cell imaging following stimulation
Analyze the kinetics of phosphorylation and spatial distribution within cells
Phospho-flow cytometry:
Fix and permeabilize cells at various time points after stimulation
Stain with PTK2B (Ab-579) Antibody and fluorescently labeled secondary antibody
Analyze by flow cytometry to quantify phosphorylation at single-cell resolution
This approach allows analysis of heterogeneity in the population response
Pulse-chase experiments:
Stimulate cells briefly, then remove or inhibit the stimulus
Monitor the persistence of Tyr579 phosphorylation over time
Compare with dephosphorylation dynamics after phosphatase inhibitor treatment
Computational modeling:
Collect quantitative data on phosphorylation kinetics under various conditions
Develop mathematical models of PTK2B activation and phosphorylation
Use models to predict and test hypotheses about feedback regulation and signal integration
PTK2B (Ab-579) Antibody can be utilized in multiple experimental approaches to study PTK2B's role in immune cell migration and function:
Immunophenotyping and signaling analysis:
Analyze PTK2B phosphorylation at Tyr579 in different immune cell subsets (B cells, T cells, macrophages, dendritic cells)
Examine how immunoreceptor engagement affects PTK2B phosphorylation
Correlate PTK2B phosphorylation status with immune cell activation markers
Migration and chemotaxis assays:
Perform Transwell or Boyden chamber migration assays with immune cells
Use PTK2B (Ab-579) Antibody to assess Tyr579 phosphorylation before, during, and after chemokine stimulation
Correlate phosphorylation levels with migration capacity
Compare wild-type cells with PTK2B-knockdown or -inhibited cells
Live cell imaging of immune synapse formation:
Use PTK2B (Ab-579) Antibody in immunofluorescence studies to visualize PTK2B localization and phosphorylation during immune synapse formation
Implement advanced microscopy techniques (TIRF, confocal) to examine spatial distribution
In vivo migration studies:
Adoptively transfer immune cells into recipient animals
Harvest cells from different tissues/organs at various time points
Analyze PTK2B phosphorylation status using PTK2B (Ab-579) Antibody
Correlate with migration and homing patterns
Functional immune assays:
Examine how PTK2B phosphorylation status correlates with:
Cytokine production
Phagocytic capacity (for macrophages and dendritic cells)
Antigen presentation
T cell proliferation and differentiation
Use PTK2B inhibitors or genetic approaches to manipulate PTK2B function and assess consequences
Integration with other signaling pathways:
Study how PTK2B phosphorylation at Tyr579 coordinates with other immune signaling pathways (e.g., TCR/BCR signaling, integrin signaling)
Examine the relationship between PTK2B and calcium mobilization in immune cell activation
Distinguishing between PTK2B (PYK2/FAK2) and its related family member FAK (PTK2) requires careful experimental design:
Antibody-based approaches:
Use highly specific antibodies targeting unique regions or phosphorylation sites
PTK2B (Ab-579) Antibody targets the region around Tyr579, which may have sequence differences from the corresponding region in FAK
Validate antibody specificity using overexpression systems or knockout controls
Perform side-by-side Western blots with anti-PTK2B and anti-FAK antibodies to compare molecular weights (FAK is approximately 125 kDa, similar to PTK2B)
Immunoprecipitation followed by mass spectrometry:
Immunoprecipitate with PTK2B (Ab-579) Antibody
Analyze the precipitated proteins by mass spectrometry
Identify peptides unique to PTK2B versus FAK
This approach can also identify specific post-translational modifications and interacting partners
Genetic approaches:
Use siRNA or shRNA specifically targeting PTK2B or FAK
Verify knockdown efficiency with gene-specific primers (qRT-PCR) and protein-specific antibodies
Analyze the differential effects of PTK2B versus FAK knockdown on cellular functions
Use CRISPR-Cas9 to generate specific knockout cell lines
Functional differentiation:
Exploit known functional differences between PTK2B and FAK:
PTK2B is calcium-responsive while FAK is generally not
PTK2B is highly expressed in specific cell types (central nervous system, hematopoietic cells) where FAK expression might be lower
Compare responses to specific stimuli known to preferentially activate one kinase over the other
Subcellular localization studies:
PTK2B phosphorylation at Tyr579 plays crucial roles in cytoskeletal reorganization and cell adhesion through multiple mechanisms:
Activation of Rho family GTPases:
Focal adhesion dynamics:
Integrin signaling integration:
Scaffold function for signaling complexes:
Phosphorylated PTK2B serves as a platform for recruiting signaling proteins involved in cytoskeletal regulation
It interacts with SRC family kinases, which phosphorylate additional cytoskeletal regulators
These interactions facilitate signal transduction from adhesion receptors to the cytoskeleton
Cell type-specific functions:
Variability in PTK2B (Ab-579) Antibody detection across different cell types can result from several factors:
Expression level differences:
PTK2B expression varies naturally between cell types
Some immune cells, neurons, and osteoclasts express relatively high levels
Epithelial cells may express lower levels
Quantify total PTK2B expression using qRT-PCR or Western blotting with antibodies against total protein
Basal phosphorylation state:
Different cell types maintain varying levels of basal PTK2B phosphorylation
This depends on intrinsic signaling activity and culture conditions
Serum starvation prior to experiments may help standardize basal phosphorylation
Epitope accessibility issues:
Protein-protein interactions may mask the epitope around Tyr579
PTK2B interacts with numerous proteins depending on cell type and activation state
Different cell types may have different PTK2B binding partners affecting epitope accessibility
Protein extraction efficiency:
Cell type-specific differences in membrane composition and cytoskeletal structure
May require optimization of lysis conditions for each cell type
Consider using different detergents or extraction methods for challenging cell types
Post-translational modifications:
Other post-translational modifications near Tyr579 might affect antibody binding
These modifications could vary between cell types
Phosphorylation at nearby residues (e.g., Tyr580) might influence epitope recognition
Technical considerations:
Several stimuli and treatments can effectively induce PTK2B phosphorylation at Tyr579:
Calcium-elevating agents:
G-protein coupled receptor (GPCR) activators:
Integrin activators:
Plating cells on fibronectin, collagen, or other ECM proteins
Integrin-activating antibodies
Manganese chloride (activates integrins)
Growth factors and cytokines:
Epidermal growth factor (EGF)
Platelet-derived growth factor (PDGF)
Cell type-specific cytokines
Mechanical stimuli:
Fluid shear stress
Substrate stiffness modulation
Cell stretching
Oxidative stress inducers:
Physiological triggers:
In immune cells: antigen receptor engagement, chemokine stimulation
In neurons: neurotransmitter stimulation, particularly activating NMDA receptors
In osteoclasts: RANKL stimulation
Therapeutic relevance:
Small molecule inhibitors targeting upstream kinases can be used to determine the pathway leading to Tyr579 phosphorylation
SRC family kinase inhibitors would be expected to reduce Tyr579 phosphorylation after stimulation
Preserving PTK2B phosphorylation status during sample preparation requires careful attention to several factors:
Rapid sample processing:
Minimize time between cell harvesting and protein extraction
Keep samples on ice throughout processing
Work efficiently to reduce phosphatase activity time
Effective phosphatase inhibition:
Include multiple phosphatase inhibitors in all buffers:
Sodium orthovanadate (1-2 mM) for tyrosine phosphatases
Sodium fluoride (5-10 mM) for serine/threonine phosphatases
β-glycerophosphate (10 mM) for serine/threonine phosphatases
Phosphatase inhibitor cocktails containing multiple inhibitors
Pre-activate sodium orthovanadate by boiling and adjusting pH to maximize inhibitory activity
Lysis buffer composition:
Use non-denaturing lysis buffer with moderate detergent concentration:
RIPA buffer (1% NP-40 or Triton X-100, 0.5% sodium deoxycholate, 0.1% SDS)
Add protease inhibitors (PMSF, aprotinin, leupeptin, pepstatin)
Include EDTA (1-2 mM) to chelate calcium and inhibit calcium-dependent proteases
Temperature control:
Maintain samples at 4°C during lysis and processing
Avoid freeze-thaw cycles of lysates
If freezing is necessary, snap-freeze in liquid nitrogen and store at -80°C
Loading buffer considerations:
Add reducing agent (DTT or β-mercaptoethanol) to SDS sample buffer immediately before use
Limit heating time during sample denaturation (5 minutes at 95°C is typically sufficient)
Consider using lower temperatures (70°C) for longer times if phosphorylation is labile
Tissue-specific considerations:
For tissues: snap-freeze immediately after collection
Use a tissue homogenizer with the appropriate buffer
Consider using phosphatase inhibitor perfusion for animal tissues when possible
Verification approach:
Run parallel samples with and without phosphatase inhibitors to demonstrate their effectiveness
Include positive controls (e.g., cells treated with pervanadate) to verify phosphoprotein detection
Several factors can influence the stability and performance of PTK2B (Ab-579) Antibody:
Storage conditions:
Buffer composition:
Physical handling:
Minimize exposure to direct light, particularly for fluorophore-conjugated versions
Avoid vortexing antibody solutions vigorously (can cause protein denaturation)
Centrifuge briefly before opening tubes to collect solution at the bottom
Chemical stability factors:
pH extremes can denature antibodies; maintain neutral pH
Reducing agents can break disulfide bonds; avoid unless specifically required
Some detergents at high concentrations can denature antibodies
Contamination issues:
Application-specific considerations:
For immunohistochemistry: fixation type and antigen retrieval method can impact epitope accessibility
For Western blotting: transfer efficiency and blocking conditions affect performance
For immunoprecipitation: binding capacity of beads and wash stringency influence results
Lot-to-lot variation:
Polyclonal antibodies like PTK2B (Ab-579) Antibody may show some variation between production lots
Test new lots alongside previous lots when possible
Consider validation experiments when switching to a new lot
Optimizing antibody dilution and incubation conditions for different applications requires systematic testing:
Western Blotting Optimization:
Antibody dilution:
Incubation conditions:
Time: Test overnight (16h) at 4°C versus 1-3 hours at room temperature
Temperature: 4°C incubations generally give cleaner results but require longer times
Agitation: Gentle rocking or shaking improves antibody access to the membrane
Blocking optimization:
Test different blocking agents (5% non-fat dry milk, 5% BSA, commercial blockers)
For phospho-specific detection, BSA is generally preferred over milk
Optimize blocking time (30 minutes to 2 hours)
Immunohistochemistry/Immunofluorescence Optimization:
Antibody dilution:
Incubation conditions:
Time: Test 1 hour at room temperature versus overnight at 4°C
Humidity: Use a humidified chamber to prevent sample drying
For tissue sections, extend incubation times compared to cell monolayers
Antigen retrieval:
Test different methods (heat-induced epitope retrieval, enzymatic retrieval)
Optimize pH and buffer composition for heat-induced retrieval
Adjust retrieval time based on signal strength and tissue integrity
ELISA Optimization:
Antibody dilution:
Incubation conditions:
Temperature: Room temperature or 37°C
Time: 1-2 hours typical for primary antibody
Shaking: Gentle orbital shaking improves binding kinetics
Optimization Table for Different Applications:
| Application | Starting Dilution | Dilution Range | Incubation Time | Temperature | Blocking Recommendation |
|---|---|---|---|---|---|
| Western Blot | 1:1000 | 1:500-1:3000 | Overnight | 4°C | 5% BSA in TBST |
| IHC | 1:100 | 1:50-1:300 | 1-2 hours | RT | 1-5% normal serum |
| IF | 1:100 | 1:50-1:200 | 1-2 hours | RT | 1-5% BSA in PBS |
| ELISA | 1:10000 | 1:5000-1:20000 | 1-2 hours | RT | 1-3% BSA in PBS |
Optimization Strategy:
Start with the middle of the recommended dilution range
Test one variable at a time while keeping others constant
Document all conditions and results systematically
Include appropriate controls with each experiment
Once optimized, maintain consistent conditions for experimental reproducibility